WallStreetZenWallStreetZen

NASDAQ: ITCI
Intra Cellular Therapies Inc Stock Ownership - Who owns Intra Cellular Therapies?

Insider buying vs selling

Have Intra Cellular Therapies Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael HalsteadEVP and General Counsel2023-11-1315,164$15.47
$234.59kBuy
Michael HalsteadEVP and General Counsel2023-11-1341,067$54.01
$2.22MSell
Michael HalsteadEVP and General Counsel2023-11-1334,836$12.73
$443.46kBuy
Michael HalsteadEVP and General Counsel2023-11-138,933$53.37
$476.75kSell
Mark NeumannEVP Chief Commercial Officer2023-11-0626,754$23.94
$640.49kBuy
Mark NeumannEVP Chief Commercial Officer2023-11-0615,639$55.02
$860.41kSell
Mark NeumannEVP Chief Commercial Officer2023-11-0626,754$55.98
$1.50MSell
Rory B. RiggsDirector2023-09-30345$52.09
$17.97kBuy
Nostrand Robert L. VanDirector2023-09-30105$52.09
$5.47kBuy
Sharon MatesChairman President CEO2023-09-1944,413$54.17
$2.41MSell

1 of 9

ITCI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ITCI insiders and whales buy or sell their stock.

ITCI Shareholders

What type of owners hold Intra Cellular Therapies Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC11.41%10,979,710$661.97MInstitution
Vanguard Group Inc8.87%8,539,725$514.86MInstitution
Blackrock Inc7.81%7,514,851$453.07MInstitution
Christopher D. Alafi6.09%5,859,318$353.26MInsider
Nlbdit 2010 Services LLC5.20%5,000,000$301.45MInsider
Moshe Alafi4.11%3,953,270$238.34MInsider
Alafi Capital Co LLC4.11%3,953,270$238.34MInsider
Wasatch Advisors LP3.95%3,803,139$229.29MInstitution
Morton I. Sosland3.78%3,638,389$219.36MInsider
Bellevue Group Ag3.29%3,170,250$191.13MInstitution

1 of 3

ITCI vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITCI77.85%22.15%Net SellingNet Selling
ELAN90.56%9.44%Net SellingNet Selling
LNTH53.82%46.18%Net SellingNet Selling
CTLT79.38%20.62%Net BuyingNet Selling
ALKS93.27%6.73%Net Selling

Intra Cellular Therapies Stock Ownership FAQ

Who owns Intra Cellular Therapies?

Intra Cellular Therapies (NASDAQ: ITCI) is owned by 89.45% institutional shareholders, 25.45% Intra Cellular Therapies insiders, and 0.00% retail investors. Christopher D. Alafi is the largest individual Intra Cellular Therapies shareholder, owning 5.86M shares representing 6.09% of the company. Christopher D. Alafi's Intra Cellular Therapies shares are currently valued at $353.26M.

If you're new to stock investing, here's how to buy Intra Cellular Therapies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.